WTAJ on MSN

Pa. Senate passes bill expanding access to cancer, ALS testing and treatment

PENNSYLVANIA (WTAJ) — Legislation to improve access to treatment for cancer and amyotrophic lateral sclerosis (ALS) in ...

AI finds existing drugs that may extend survival for ALS patients

The study is a promising breakthrough that could eventually prove key to understanding the disease’s mysterious origins, its ...
clinicaladvisor.com

Amyotrophic Lateral Sclerosis: Update for the Primary Care Clinician

A neurologist and a multidisciplinary team are required for the management of ALS. Whenever possible, primary care clinicians should refer the patient to a specialized ALS clinic. Treatments to manage ...
Medindia

Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis

Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announced dosing of the first participant in its Phase ...
ALS News Today

Early PrimeC use slows ALS progression, reduces complication risk

Early PrimeC treatment slowed functional decline and reduced the risk of death or ALS complications for ALS patients in a ...
National Academies of Sciences%2c Engineering%2c and Medicine

Amyotrophic Lateral Sclerosis: Accelerating Treatments and Improving Quality of Life

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, invariably fatal neurological disease. Individuals affected by ALS include those living with ALS, their caregivers, presymptomatic ...

Additional Phase 2 Data of AL-S Pharma's Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

Results supported by key neuroaxonal injury biomarkers pNfH and NfL after six months of treatment AP-101 is an investigational human-derived antibody therapeutic that selectively targets the misfolded ...